Drug manufacturer Mylan is facing scrutiny over price hikes of EpiPen allergy medication.
Drug manufacturer Mylan is facing scrutiny over price hikes of EpiPen allergy medication. Mark Zaleski AP
Drug manufacturer Mylan is facing scrutiny over price hikes of EpiPen allergy medication. Mark Zaleski AP

EpiPen maker faces scrutiny over 450 percent price hike of vital allergy drug

August 24, 2016 7:03 PM